| Literature DB >> 28078128 |
Joseph Yoo1, C Andrew Kistler2, Linda Yan1, Andrew Dargan1, Ali A Siddiqui2.
Abstract
Endoscopic ultrasound (EUS) has become a mainstay in assisting in the diagnosis and staging of pancreatic cancer. In addition, EUS provides a modality to treat chronic pain through celiac plexus neurolysis. Currently, there is growing data and utilization of EUS in more diverse and innovative applications aimed at providing more sophisticated diagnostic, prognostic and therapeutic options for patients with pancreatic cancer. EUS delivery of chemotherapy, viral and biological vectors and fiducial markers may eventually revolutionize the way clinicians approach the care of a patient with pancreatic cancer.Entities:
Keywords: Endoscopic ultrasound (EUS); fiducial markers; fine needle injection (FNI); immunotherapy; pancreatic cancer
Year: 2016 PMID: 28078128 PMCID: PMC5177581 DOI: 10.21037/jgo.2016.08.07
Source DB: PubMed Journal: J Gastrointest Oncol ISSN: 2078-6891